Growth and Puberty in Children with Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBD) are gastrointestinal tract pathologies of unknown etiology; they have an alternating trend, with active and silent phases. IBD are classified in two main forms: ulcerative colitis (UC) and Crohn’s disease (CD). Both have chronic and recurrent course, gastrointestinal symptoms, and extraintestinal manifestations. The altered immune response role seems to be important both in UC and CD. In the majority of cases, CD begins with abdominal pain, diarrhea, decrease in appetite, and weight loss; there can be also perianal fistulas, rhagades, and perianal recurrent abscesses. In addition, retarded growth and delayed puberty can precede the development of the disease or can even be predominant at onset. Growth retardation is found in 40% of IBD patients, but the underlying mechanism of this and other extra-intestinal manifestations are partially known: the main hypotheses are represented by malnutrition and inflammatory response during the active phase of the disease. The increased level of pro-inflammatory cytokines can influence growth, but also the onset of puberty and its progression. In addition, it could be essential to clarify the role and the possible effects of all the currently used treatments concerning growth failure and delayed puberty.

[1]  T. Pizarro,et al.  Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease , 2020, Nature Reviews Gastroenterology & Hepatology.

[2]  L. Peyrin-Biroulet,et al.  Targeting the gut layers in Crohn’s disease: mucosal or transmural healing? , 2020, Expert review of gastroenterology & hepatology.

[3]  B. Koletzko,et al.  Partial enteral nutrition has no benefit on bone health but improves growth in paediatric patients with quiescent or mild Crohn's disease. , 2020, Clinical nutrition.

[4]  N. Gupta,et al.  Introduction to and Screening Visit Results of the Multicenter Pediatric Crohn's Disease Growth Study. , 2020, Inflammatory bowel diseases.

[5]  M. Neovius,et al.  Adult height in patients with childhood‐onset inflammatory bowel disease: a nationwide population‐based cohort study , 2020, Alimentary pharmacology & therapeutics.

[6]  B. Ranchin,et al.  Efficacy and safety of recombinant growth hormone treatment in children with growth retardation related to long-term glucocorticosteroid therapy. , 2019, Annales d'endocrinologie.

[7]  G. A. P. Silva,et al.  Linear growth and bone metabolism in pediatric patients with inflammatory bowel disease. , 2019, Jornal de pediatria.

[8]  T. Ishige Growth failure in pediatric onset inflammatory bowel disease: mechanisms, epidemiology, and management. , 2019, Translational pediatrics.

[9]  R. Shamir,et al.  Anthropometric Measures in Adolescents With Inflammatory Bowel Disease: A Population-Based Study. , 2018, Inflammatory bowel diseases.

[10]  J. D. del Campo,et al.  Modulation of faecal metagenome in Crohn’s disease: Role of microRNAs as biomarkers , 2018, World journal of gastroenterology.

[11]  J. Doré,et al.  Mucosal healing and bacterial composition in response to enteral nutrition versus steroid based induction therapy - a randomized prospective clinical trial in children with Crohn's disease. , 2018, Journal of Crohn's & colitis.

[12]  Y. Naito,et al.  Gut microbiota in the pathogenesis of inflammatory bowel disease , 2018, Clinical Journal of Gastroenterology.

[13]  C. Croce,et al.  MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers — their effects and therapeutic potentials , 2017, Current opinion in pharmacology.

[14]  David V. Evans,et al.  An Update on Inflammatory Bowel Disease. , 2017, Primary care.

[15]  M. Neovius,et al.  Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014 , 2017, British Medical Journal.

[16]  I. Monteiro,et al.  Diagnosis and management of inflammatory bowel disease in children , 2017, British Medical Journal.

[17]  J. Kopchick,et al.  Growth Hormone Resistance—Special Focus on Inflammatory Bowel Disease , 2017, International journal of molecular sciences.

[18]  D. Tanyingoh,et al.  Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases , 2017, The American Journal of Gastroenterology.

[19]  Liu Hong,et al.  Role of MiRNAs in Inflammatory Bowel Disease , 2017, Digestive Diseases and Sciences.

[20]  M. Eisenhut,et al.  IBD immunopathogenesis: A comprehensive review of inflammatory molecules. , 2017, Autoimmunity reviews.

[21]  R. Russell,et al.  Disease Status and Pubertal Stage Predict Improved Growth in Antitumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease , 2017, Journal of pediatric gastroenterology and nutrition.

[22]  M. Kawahara,et al.  Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease , 2017, Journal of Gastroenterology.

[23]  C. Farquharson,et al.  Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions. , 2016, Endocrine reviews.

[24]  H. Herfarth,et al.  Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases , 2016, Inflammatory bowel diseases.

[25]  S. Saeed,et al.  Inflammatory Bowel Disease in Children and Adolescents. , 2021, Advances in pediatrics.

[26]  G. Rogler,et al.  Extraintestinal Manifestations of Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[27]  Christoph Beglinger,et al.  The role and utility of faecal markers in inflammatory bowel disease , 2015, Therapeutic advances in gastroenterology.

[28]  E. Semikina,et al.  Cytokine profile in children with inflammatory bowel disease , 2014, Biochemistry (Moscow).

[29]  C. Braegger,et al.  Early-onset Crohn’s disease is a risk factor for smaller final height , 2014, European journal of gastroenterology & hepatology.

[30]  G. Guariso,et al.  Crohn's disease and growth deficiency in children and adolescents. , 2014, World journal of gastroenterology.

[31]  A. Griffiths,et al.  Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. , 2014, Journal of Crohn's & colitis.

[32]  V. Locatelli,et al.  Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis , 2014, International journal of endocrinology.

[33]  I. Sanderson Growth problems in children with IBD , 2014, Nature Reviews Gastroenterology &Hepatology.

[34]  Carl A. Anderson,et al.  Genetic studies of Crohn's disease: Past, present and future , 2014, Best practice & research. Clinical gastroenterology.

[35]  O. Mäkitie,et al.  Compromised peak bone mass in patients with inflammatory bowel disease--a prospective study. , 2014, The Journal of pediatrics.

[36]  R. Hill Update on nutritional status, body composition and growth in paediatric inflammatory bowel disease. , 2014, World journal of gastroenterology.

[37]  A. Ananthakrishnan,et al.  Review article: vitamin D and inflammatory bowel diseases , 2014, Alimentary pharmacology & therapeutics.

[38]  D. Iliopoulos,et al.  MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. , 2013, Gastroenterology.

[39]  L. Denson,et al.  Delays in puberty, growth, and accrual of bone mineral density in pediatric Crohn's disease: despite temporal changes in disease severity, the need for monitoring remains. , 2013, The Journal of pediatrics.

[40]  M. Collet,et al.  Puberté, fertilité et maladies chroniques , 2013 .

[41]  A. Besançon,et al.  [Puberty, fertility and chronic diseases]. , 2013, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[42]  V. Marchand The toddler who is falling off the growth chart. , 2012, Paediatrics & child health.

[43]  C. Elias,et al.  Leptin signaling and circuits in puberty and fertility , 2012, Cellular and Molecular Life Sciences.

[44]  H. El‐Serag,et al.  Natural History of Pediatric-onset Inflammatory Bowel Disease: A Systematic Review , 2012, Journal of clinical gastroenterology.

[45]  A. Griffiths,et al.  Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children. , 2012, Gastroenterology.

[46]  P. Marques‐Vidal,et al.  Impact of Disease and Treatments on Growth and Puberty of Pediatric Patients with Inflammatory Bowel Disease , 2012, Digestion.

[47]  A. Akobeng,et al.  The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD). , 2012, Journal of Crohn's & colitis.

[48]  A. Griffiths,et al.  Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[49]  P. Adamski,et al.  Horizontal Distribution of the Fecal Microbiota in Adolescents With Inflammatory Bowel Disease , 2012, Journal of pediatric gastroenterology and nutrition.

[50]  E. Vittinghoff,et al.  Sex differences in statural growth impairment in Crohn's disease: Role of IGF‐1 , 2011, Inflammatory bowel diseases.

[51]  Beppie van den Bogaerde,et al.  Clinical practice , 2011, European Journal of Pediatrics.

[52]  V. de Lédinghen,et al.  Mucosal healing with methotrexate in Crohn’s disease: a prospective comparative study with azathioprine and infliximab , 2011, Alimentary pharmacology & therapeutics.

[53]  P. Rzehak,et al.  Childhood onset inflammatory bowel disease: predictors of delayed diagnosis from the CEDATA German-language pediatric inflammatory bowel disease registry. , 2011, The Journal of pediatrics.

[54]  R. Russell,et al.  Improvement in Growth of Children With Crohn Disease Following Anti-TNF-α Therapy Can Be Independent of Pubertal Progress and Glucocorticoid Reduction , 2011, Journal of pediatric gastroenterology and nutrition.

[55]  M. DeBoer,et al.  Puberty Is Delayed in Male Mice With Dextran Sodium Sulfate Colitis Out of Proportion to Changes in Food Intake, Body Weight, and Serum Levels of Leptin , 2011, Pediatric Research.

[56]  J. Hirschhorn,et al.  Association of Linear Growth Impairment in Pediatric Crohn's Disease and a Known Height Locus: A Pilot Study , 2010, Annals of human genetics.

[57]  C. O'Morain,et al.  Therapeutic benefits of budesonide in gastroenterology , 2010, Therapeutic advances in chronic disease.

[58]  M. Oliva-Hemker,et al.  Nutritional considerations in pediatric inflammatory bowel disease , 2010, Expert review of gastroenterology & hepatology.

[59]  A. Day,et al.  Infliximab improves inflammation and anthropometric measures in pediatric Crohn's disease , 2010, Journal of gastroenterology and hepatology.

[60]  W. Fraser,et al.  IL-6 May Modulate the Skeletal Response to Glucocorticoids During Exacerbations of Inflammatory Bowel Disease , 2010, Calcified Tissue International.

[61]  S. Kugathasan,et al.  Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD. , 2009, Gastroenterology clinics of North America.

[62]  S. Cohn,et al.  Colitis causes delay in puberty in female mice out of proportion to changes in leptin and corticosterone , 2010, Journal of Gastroenterology.

[63]  A. Griffiths,et al.  Long‐term outcome of maintenance infliximab therapy in children with Crohn's disease , 2009, Inflammatory bowel diseases.

[64]  R. Shamir Nutritional Aspects in Inflammatory Bowel Disease , 2009, Journal of pediatric gastroenterology and nutrition.

[65]  J. Sarles,et al.  Efficacy of Infliximab in Pediatric Crohn's Disease: A Randomized Multicenter Open‐Label Trial Comparing Scheduled to On Demand Maintenance Therapy , 2009, Inflammatory bowel diseases.

[66]  T. Raivio,et al.  Bone turnover and metabolism in paediatric patients with inflammatory bowel disease treated with systemic glucocorticoids. , 2008, European journal of endocrinology.

[67]  S. Brant,et al.  MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. , 2008, Gastroenterology.

[68]  A. Griffiths,et al.  Guidelines for the management of growth failure in childhood inflammatory bowel disease. , 2008, Inflammatory bowel diseases.

[69]  T. Raivio,et al.  P147 Bone Turnover in Paediatric Patients with Inflammatory Bowel Disease Treated with Systemic Glucocorticoids , 2008 .

[70]  M. Castro,et al.  Positive impact of blocking tumor necrosis factor α on the nutritional status in pediatric Crohn’s disease patients , 2008, International Journal of Colorectal Disease.

[71]  R. Baldassano,et al.  Gender Differences in Presentation and Course of Disease in Pediatric Patients With Crohn Disease , 2007, Pediatrics.

[72]  N. Afzal,et al.  Infliximab Delays but Does Not Avoid the Need for Surgery in Treatment-Resistant Pediatric Crohn’ Disease , 2007, Digestive Diseases and Sciences.

[73]  M. Phillip,et al.  Growth retardation in pediatric Crohn's disease: Pathogenesis and interventions , 2007, Inflammatory bowel diseases.

[74]  Athos Bousvaros,et al.  The Crohn’s and Colitis Foundation of America , 2018, The Grants Register 2019.

[75]  A. Griffiths,et al.  Linear Growth Improves during Infliximab Therapy in Children with Chronically Active Severe Crohn's Disease , 2007, Inflammatory bowel diseases.

[76]  A. Griffiths,et al.  Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. , 2007, Gastroenterology.

[77]  S. Ahmed,et al.  The Effects of Recombinant Human Growth Hormone on Linear Growth in Children with Crohn's Disease and Short Stature , 2007, Journal of pediatric endocrinology & metabolism : JPEM.

[78]  V. Macrae,et al.  The Role of Pro-Inflammatory Cytokines in Inflammatory Bowel Disease Growth Retardation , 2006, Journal of pediatric gastroenterology and nutrition.

[79]  M. Savage,et al.  Clinical Features Affecting Final Adult Height in Patients With Pediatric-Onset Crohn's Disease , 2006, Pediatrics.

[80]  S. Uccini,et al.  Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[81]  Devinder Kumar,et al.  Surgery results in significant improvement in growth in children with Crohn’s disease refractory to medical therapy , 2006, Pediatric Surgery International.

[82]  P. Rutgeerts,et al.  Laboratory markers in IBD: useful, magic, or unnecessary toys? , 2006, Gut.

[83]  H. Drummond,et al.  Edinburgh Research Explorer Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease , 2022 .

[84]  R. Balicer,et al.  Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease , 2005, Gut.

[85]  J. Auwerx,et al.  Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ , 2005, The Journal of experimental medicine.

[86]  D. Felsenberg,et al.  Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[87]  M. Savage,et al.  IGFs and IGFBPs in GH insensitivity. , 2005, Endocrine development.

[88]  E. Leshinsky‐Silver,et al.  Pediatric Crohn's Disease and Growth Retardation: The Role of Genotype, Phenotype, and Disease Severity , 2004, Pediatrics.

[89]  M. Kiely,et al.  Vitamin K Status in Patients with Crohn's Disease and Relationship to Bone Turnover , 2004, The American Journal of Gastroenterology.

[90]  S. Abrams,et al.  Zinc Metabolism in Adolescents with Crohn's Disease , 2004, Pediatric Research.

[91]  A. Griffiths Specificities of inflammatory bowel disease in childhood. , 2004, Best practice & research. Clinical gastroenterology.

[92]  Keesook Lee,et al.  Molecular Mechanism of Suppression of Testicular Steroidogenesis by Proinflammatory Cytokine Tumor Necrosis Factor Alpha , 2004, Molecular and Cellular Biology.

[93]  L. Bodin,et al.  Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial , 2004 .

[94]  M. Savage,et al.  Anti-Inflammatory and Growth-Stimulating Effects Precede Nutritional Restitution During Enteral Feeding in Crohn Disease , 2004, Journal of pediatric gastroenterology and nutrition.

[95]  B. Sandhu,et al.  Presenting features of inflammatory bowel disease in Great Britain and Ireland , 2003, Archives of disease in childhood.

[96]  H. Bettiol,et al.  Acompanhamento do crescimento , 2003 .

[97]  S. Murch,et al.  High‐dose azathioprine in children with inflammatory bowel disease , 2003, Alimentary pharmacology & therapeutics.

[98]  M. Savage,et al.  Delayed Puberty Associated with Inflammatory Bowel Disease , 2003, Pediatric Research.

[99]  R. Baldassano,et al.  Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients , 2002, American Journal of Gastroenterology.

[100]  M. Mearin,et al.  Adult height in patients with early onset of Crohn's disease , 2002, Gut.

[101]  S. Cucchiara,et al.  Azathioprine in paediatric inflammatory bowel disease: an Italian multicentre survey , 2002, Alimentary pharmacology & therapeutics.

[102]  S. Poole,et al.  Anorexia in a rat model of colitis: interaction of interleukin-1 and hypothalamic serotonin , 2002, Brain Research.

[103]  M. Adamo,et al.  Dexamethasone decreases serum and liver IGF-I and maintains liver IGF-I mRNA in parenterally fed rats. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[104]  P. Clayton,et al.  Low Serum Concentrations of Insulin-like Growth Factor-I in Children with Active Crohn Disease: Effect of Enteral Nutritional Support and Glutamine Supplementation , 2002, Scandinavian journal of gastroenterology.

[105]  J. Markowitz,et al.  A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. , 2000, Gastroenterology.

[106]  M. Farthing,et al.  Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis , 2000, Gut.

[107]  D. Perrett,et al.  The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. , 2000, Gastroenterology.

[108]  Katsuki Ito,et al.  Interleukin‐6 and soluble interleukin‐6 receptor in the colonic mucosa of inflammatory bowel disease , 1999, Journal of gastroenterology and hepatology.

[109]  B. Kirschner,et al.  Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease. , 1998, Gastroenterology.

[110]  M. Savage,et al.  Responsiveness of IGF‐I and IGFBP‐3 to therapeutic intervention in children and adolescents with Crohn's disease , 1998, Clinical endocrinology.

[111]  A. Parfitt,et al.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.

[112]  C. Ohlsson,et al.  Dexamethasone Impairs Growth Hormone (GH)-Stimulated Growth by Suppression of Local Insulin-Like Growth Factor (IGF)-I Production and Expression of GH- and IGF-I-Receptor in Cultured Rat Chondrocytes. , 1998, Endocrinology.

[113]  DB Allen,et al.  Influence of inhaled corticosteroids on growth: a pediatric endocrinologist's perspective , 1998, Acta paediatrica.

[114]  C. Rubin,et al.  Experimental colitis impairs linear bone growth independent of nutritional factors. , 1997, Journal of pediatric gastroenterology and nutrition.

[115]  C. Mantzoros,et al.  A Longitudinal Assessment of Hormonal and Physical Alterations during Normal Puberty in Boys. v. Rising Leptin Levels May Signal the Onset of Puberty* , 2022 .

[116]  A. Rogol,et al.  A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. III. The neuroendocrine growth hormone axis during late prepuberty. , 1996, The Journal of clinical endocrinology and metabolism.

[117]  D. Allen Growth suppression by glucocorticoid therapy. , 1996, Endocrinology and metabolism clinics of North America.

[118]  M. Corey,et al.  Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. , 1996, Gut.

[119]  H. Büller,et al.  Mechanisms of Growth Retardation, Drug Therapy, and Nutritional Support in Pediatric Inflammatory Bowel Disease: A Workshop Sponsored by the North American and European Societies for Pediatric Gastroenterology and Nutrition , 1995, Inflammatory bowel diseases.

[120]  W. Walker,et al.  Profile of IGF-binding proteins secreted by intestinal epithelial cells changes with differentiation. , 1994, The American journal of physiology.

[121]  A. Ferguson,et al.  Juvenile onset inflammatory bowel disease: height and body mass index in adult life , 1994, BMJ.

[122]  V. Fazio,et al.  The Results of Strictureplasty in Pediatric Patients with Multifocal Crohn's Disease , 1994, Journal of pediatric gastroenterology and nutrition.

[123]  C. Brain,et al.  Growth and puberty in chronic inflammatory bowel disease. , 1994, Bailliere's clinical gastroenterology.

[124]  E. Hunziker,et al.  Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. , 1994, The Journal of clinical investigation.

[125]  J. Karlberg,et al.  Longitudinal Growth in Children and Adolescents with Inflammatory Bowel Disease , 1994, Journal of pediatric gastroenterology and nutrition.

[126]  N. Belova,et al.  Blockade by interleukin-1-alpha of nitricoxidergic control of luteinizing hormone-releasing hormone release in vivo and in vitro. , 1994, Neuroimmunomodulation.

[127]  J. Markowitz,et al.  Growth failure in pediatric inflammatory bowel disease. , 1993, Journal of pediatric gastroenterology and nutrition.

[128]  M. Savage,et al.  Urinary Growth Hormone in Growth‐Impaired Children with Chronic Inflammatory Bowel Disease , 1993, Journal of pediatric gastroenterology and nutrition.

[129]  A. Giustina,et al.  The role of glucocorticoids in the regulation of growth hormone secretion Mechanisms and clinical significance , 1992, Trends in Endocrinology & Metabolism.

[130]  R. Lange,et al.  Gastric emptying in childhood inflammatory bowel disease: nutritional and pathologic correlates. , 1992, The American journal of gastroenterology.

[131]  L. Dunkel,et al.  Delayed puberty , 2018, Rapid Paediatrics and Child Health.

[132]  C. Edwards,et al.  Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease. , 1981, Gut.

[133]  A. Tenore,et al.  Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease. , 1977, The Journal of clinical endocrinology and metabolism.